Cellular and Molecular Life Sciences,
Journal Year:
2022,
Volume and Issue:
79(4)
Published: April 1, 2022
Abstract
Microglia
are
specialized
dynamic
immune
cells
in
the
central
nervous
system
(CNS)
that
plays
a
crucial
role
brain
homeostasis
and
disease
states.
Persistent
neuroinflammation
is
considered
hallmark
of
many
neurodegenerative
diseases,
including
Alzheimer’s
(AD),
Parkinson's
(PD),
Huntington’s
(HD),
amyotrophic
lateral
sclerosis
(ALS)
primary
progressive
multiple
(MS).
Colony
stimulating
factor
1-receptor
(CSF-1R)
predominantly
expressed
on
microglia
its
expression
significantly
increased
diseases.
Cumulative
findings
have
indicated
CSF-1R
inhibitors
can
beneficial
effects
preclinical
models.
Research
using
has
now
been
extended
into
non-human
primates
humans.
This
review
article
summarizes
most
recent
advances
different
conditions
AD,
PD,
HD,
ALS
MS.
Potential
challenges
for
translating
these
clinical
practice
presented.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: July 12, 2023
Abstract
Studies
in
neurodegenerative
diseases,
including
Alzheimer’s
disease,
Parkinson’s
disease
and
Amyotrophic
lateral
sclerosis,
Huntington’s
so
on,
have
suggested
that
inflammation
is
not
only
a
result
of
neurodegeneration
but
also
crucial
player
this
process.
Protein
aggregates
which
are
very
common
pathological
phenomenon
can
induce
neuroinflammation
further
aggravates
protein
aggregation
neurodegeneration.
Actually,
even
happens
earlier
than
aggregation.
Neuroinflammation
induced
by
genetic
variations
CNS
cells
or
peripheral
immune
may
deposition
some
susceptible
population.
Numerous
signaling
pathways
range
been
to
be
involved
the
pathogenesis
neurodegeneration,
although
they
still
far
from
being
completely
understood.
Due
limited
success
traditional
treatment
methods,
blocking
enhancing
inflammatory
considered
promising
strategies
for
therapy
many
them
got
exciting
results
animal
models
clinical
trials.
Some
them,
few,
approved
FDA
usage.
Here
we
comprehensively
review
factors
affecting
major
pathogenicity
sclerosis.
We
summarize
current
strategies,
both
clinic,
diseases.
Journal of Neuroinflammation,
Journal Year:
2021,
Volume and Issue:
18(1)
Published: Nov. 6, 2021
Microglia
are
emerging
as
critical
regulators
of
neuronal
function
and
behavior
in
nearly
every
area
neuroscience.
Initial
reports
focused
on
classical
immune
functions
microglia
pathological
contexts,
however,
immunological
concepts
from
these
studies
have
been
applied
to
describe
neuro-immune
interactions
the
absence
disease,
injury,
or
infection.
Indeed,
terms
such
'microglia
activation'
'neuroinflammation'
used
ubiquitously
changes
disparate
contexts;
particularly
stress
research,
where
prompt
undue
comparisons
conditions.
This
creates
a
barrier
for
investigators
new
neuro-immunology
ultimately
hinders
our
understanding
effects
microglia.
As
more
seek
understand
role
neurobiology
behavior,
it
is
increasingly
important
develop
standard
methods
study
define
microglial
phenotype
function.
In
this
review,
we
summarize
primary
research
physiological
contexts.
Further,
propose
framework
better
microglia1
chronic
stress.
approach
will
enable
precise
characterization
different
which
should
facilitate
development
microglia-directed
therapeutics
psychiatric
neurological
disease.
Neural Regeneration Research,
Journal Year:
2021,
Volume and Issue:
17(4), P. 705 - 705
Published: Aug. 29, 2021
Microglia
are
the
resident
macrophages
of
central
nervous
system.
possess
varied
morphologies
and
functions.
Under
normal
physiological
conditions,
microglia
mainly
exist
in
a
resting
state
constantly
monitor
their
microenvironment
survey
neuronal
synaptic
activity.
Through
C1q,
C3
CR3
"Eat
Me"
CD47
SIRPα
"Don't
Eat
complement
pathways,
as
well
other
pathways
such
CX3CR1
signaling,
regulate
pruning,
process
crucial
for
promotion
synapse
formation
regulation
activity
plasticity.
By
mediating
play
an
important
role
experience-dependent
plasticity
barrel
cortex
visual
after
whisker
removal
or
monocular
deprivation,
also
learning
memory,
including
modulation
memory
strength,
forgetfulness,
quality.
As
response
to
brain
injury,
infection
neuroinflammation,
become
activated
increase
number.
Activated
change
amoeboid
shape,
migrate
sites
inflammation
secrete
proteins
cytokines,
chemokines
reactive
oxygen
species.
These
molecules
released
by
can
lead
deficits
associated
with
aging,
Alzheimer's
disease,
traumatic
HIV-associated
neurocognitive
disorder,
neurological
mental
disorders
autism,
depression
post-traumatic
stress
disorder.
With
focus
on
recently
published
literature,
here
we
reviewed
studies
investigating
how
modulate
disease-related
deficits.
summarizing
function
these
processes,
aim
provide
overview
discuss
possibility
manipulation
therapeutic
ameliorate
cognitive
disorders.
Neuron,
Journal Year:
2022,
Volume and Issue:
110(21), P. 3484 - 3496
Published: Oct. 7, 2022
Persistent
neurological
and
neuropsychiatric
symptoms
affect
a
substantial
fraction
of
people
after
COVID-19
represent
major
component
the
post-acute
syndrome,
also
known
as
long
COVID.
Here,
we
review
what
is
understood
about
pathobiology
impact
on
CNS
discuss
possible
neurobiological
underpinnings
cognitive
affecting
survivors.
We
propose
chief
mechanisms
that
may
contribute
to
this
emerging
health
crisis.
Translational Psychiatry,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: June 22, 2022
Abstract
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
leading
to
loss
of
cognitive
abilities
and
ultimately,
death.
With
no
cure
available,
limited
treatments
mostly
focus
on
symptom
management.
Identifying
early
changes
in
the
course
may
provide
new
therapeutic
targets
halt
or
reverse
progression.
Clinical
studies
have
shown
that
cortical
hippocampal
hyperactivity
are
feature
shared
by
patients
stages
disease,
progressing
hypoactivity
during
later
neurodegeneration.
The
exact
mechanisms
causing
neuronal
excitability
not
fully
characterized;
however,
animal
cell
models
provided
insights
into
some
factors
involved
this
phenotype.
In
review,
we
summarize
evidence
for
over
AD
onset
progression
molecular
underpinning
these
differences.
Specifically,
discuss
contributors
aberrant
excitability,
including
abnormal
levels
intracellular
Ca
2+
glutamate,
pathological
amyloid
β
(Aβ)
tau,
genetic
risk
factors,
APOE
,
impaired
inhibitory
interneuron
glial
function.
light
recent
research
indicating
hyperexcitability
could
be
predictive
marker
dysfunction,
further
argue
phenotype
leveraged
improve
diagnosis
treatment
AD,
present
potential
future
development.